These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 31560045)
1. Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease. Abu-Sbeih H; Wang Y Inflamm Bowel Dis; 2020 Apr; 26(5):662-668. PubMed ID: 31560045 [TBL] [Abstract][Full Text] [Related]
2. Immune-checkpoint inhibitors induced diarrhea and colitis: a review of incidence, pathogenesis and management. Abu-Sbeih H; Ali FS; Wang Y Curr Opin Gastroenterol; 2020 Jan; 36(1):25-32. PubMed ID: 31609734 [TBL] [Abstract][Full Text] [Related]
3. Systematic review with meta-analysis: effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced enterocolitis. Ibraheim H; Baillie S; Samaan MA; Abu-Sbeih H; Wang Y; Talley NJ; P Jones M; Powell N Aliment Pharmacol Ther; 2020 Nov; 52(9):1432-1452. PubMed ID: 32920854 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review. Nakane T; Mitsuyama K; Yamauchi R; Kakuma T; Torimura T Kurume Med J; 2023 Jul; 68(2):43-52. PubMed ID: 37100606 [TBL] [Abstract][Full Text] [Related]
5. Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis. Jain A; Lipson EJ; Sharfman WH; Brant SR; Lazarev MG World J Gastroenterol; 2017 Mar; 23(11):2023-2028. PubMed ID: 28373768 [TBL] [Abstract][Full Text] [Related]
6. British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis. Powell N; Ibraheim H; Raine T; Speight RA; Papa S; Brain O; Green M; Samaan MA; Spain L; Yousaf N; Hunter N; Eldridge L; Pavlidis P; Irving P; Hayee B; Turajlic S; Larkin J; Lindsay JO; Gore M Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):679-697. PubMed ID: 32553146 [TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab. Alexander JL; Ibraheim H; Sheth B; Little J; Khan MS; Richards C; Hunter N; Chauhan D; Ratnakumaran R; McHugh K; Pinato DJ; Nathan P; Choy J; Crusz SM; Furness A; Turajlic S; Pickering L; Larkin J; Teare JP; Papa S; Speight A; Sharma A; Powell N J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34233964 [TBL] [Abstract][Full Text] [Related]
8. Management of Patients With Immune Checkpoint Inhibitor-Induced Enterocolitis: A Systematic Review. Collins M; Soularue E; Marthey L; Carbonnel F Clin Gastroenterol Hepatol; 2020 May; 18(6):1393-1403.e1. PubMed ID: 32007539 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy induced enterocolitis and gastritis - What to do and when? Cheung VTF; Brain O Best Pract Res Clin Gastroenterol; 2020; 48-49():101703. PubMed ID: 33317787 [TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Inhibitor-Mediated Diarrhea and Colitis: A Clinical Review. Gong Z; Wang Y JCO Oncol Pract; 2020 Aug; 16(8):453-461. PubMed ID: 32584703 [TBL] [Abstract][Full Text] [Related]